Lilly PR — TRANSCEND T2D-1 Results 2026

Lilly Press Release

Eli Lilly

Study Details

Study Design

Phase 3 results announcement

Indication

Type 2 diabetes

Intervention

Retatrutide

Species

Human

Risk of Bias Assessment

Press release only